Thanks to visit codestin.com
Credit goes to andrewscarborough.substack.com

Andrew’s Substack

Home
Archive
About
Merry Christmas everyone
A time for reflection, whether you celebrate or not - and a call to action.
 • Andrew Scarborough
Hype surrounding IDH inhibitors is justified, but issues persist
Since the FDA approval of IDH inhibitor vorasidenib to treat IDH-mutant grade 2 gliomas in August 2024, there have been wide-scale campaigns to improve…
 • Andrew Scarborough
Cancer detectives: Finding the Cures
My thoughts on this new TV series
 • Andrew Scarborough
A new study helps to combat a persistent myth about nutritional and therapeutic ketosis
And with it, cancer cachexia?
 • Andrew Scarborough
A significant moment for Ketogenic Metabolic Therapy in brain tumour research?
Our session proposal for EANO 2026 has been submitted.
 • Andrew Scarborough
Self experimentation, new research and returning to work in the NHS
I set myself a number of goals over the next 3 months, let's see how that pans out.
 • Andrew Scarborough
Insights on the gut microbiome and brain cancer from EANO 2025
Talks I found most interesting - Part 2
 • Andrew Scarborough
Highlights from EANO 2025
Talks I found most interesting - Part 1
 • Andrew Scarborough
Andrew’s Substack
Follow the latest news on emerging brain tumour treatments with commentary from a 10+ year survivor of a high grade glioma. News features on metabolic treatments and novel therapies will be prioritised.

Andrew’s Substack

AboutArchiveSitemap
© 2026 Andrew Scarborough · Privacy ∙ Terms ∙ Collection notice
Codestin Search App Start your SubstackGet the app
Substack is the home for great culture